These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29998439)

  • 1. Hypolipidemic and Hepatoprotective Effects of a Polyprenol-Containing Drug in Patients with Acute Coronary Syndrome.
    Vyshlov EV; Tsoy EI; Sultanov VS; Trusov VB; Ryabov VV
    Bull Exp Biol Med; 2018 Jul; 165(3):319-321. PubMed ID: 29998439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the Effects of Cucumis sativus Seed Extract on Serum Lipids in Adult Hyperlipidemic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Soltani R; Hashemi M; Farazmand A; Asghari G; Heshmat-Ghahdarijani K; Kharazmkia A; Ghanadian SM
    J Food Sci; 2017 Jan; 82(1):214-218. PubMed ID: 27886382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy.
    Blair SN; Capuzzi DM; Gottlieb SO; Nguyen T; Morgan JM; Cater NB
    Am J Cardiol; 2000 Jul; 86(1):46-52. PubMed ID: 10867091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
    J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of hypolipidemic and antioxidative effect of 'Ajwa' (Phoenix dactylifera L.) date seed-extract in high-fat diet-induced hyperlipidemic rat model.
    Khan TJ; Kuerban A; Razvi SS; Mehanna MG; Khan KA; Almulaiky YQ; Faidallah HM
    Biomed Pharmacother; 2018 Nov; 107():675-680. PubMed ID: 30125841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial.
    Kuriyan R; Kumar DR; R R; Kurpad AV
    BMC Complement Altern Med; 2010 Jun; 10():27. PubMed ID: 20553629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: a double-blind placebo-controlled randomized clinical trial.
    Hajmohammadi Z; Heydari M; Nimrouzi M; Faridi P; Zibaeenezhad MJ; Omrani GR; Shams M
    J Integr Med; 2018 Jan; 16(1):45-50. PubMed ID: 29397092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Efficacy and Safety of Combination Medication of Atorvastatin and a Herbal Formula Containing Salvia miltiorrhiza and Pueraria lobata on Hyperlipidemia.
    Cheung DW; Koon CM; Wong PH; Yau KC; Wat E; Hung AS; Wang YP; Lau KM; Ko CH; Chan JY; Waye MM; Fung KP
    Phytother Res; 2017 Oct; 31(10):1579-1589. PubMed ID: 28840970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
    Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
    J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofibrate and lipid profile.
    Chandler HA; Batchelor AJ
    Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract]   [Full Text] [Related]  

  • 15. No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial.
    Lee CY; Yu MC; Perng WT; Lin CC; Lee MY; Chang YL; Lai YY; Lee YC; Kuan YH; Wei JC; Shih HC
    Chin J Integr Med; 2017 Aug; 23(8):581-588. PubMed ID: 27838874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic potential of sterol containing fractions of Jolyna laminarioides: a brown alga.
    Ruqqia -; Sohail N; Taj D; Sarwar G; Sultana V; Ara J; Haque SE
    Pak J Pharm Sci; 2020 Jan; 33(1):169-174. PubMed ID: 32122845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).
    Pitt B; Loscalzo J; Monyak J; Miller E; Raichlen J
    Am J Cardiol; 2012 May; 109(9):1239-46. PubMed ID: 22360820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate effect of fluvastatin on lipid levels in acute coronary syndrome.
    Ostadal P; Alan D; Vejvoda J; Cepova J; Kukacka J; Blasko P; Martinkovicova L; Vojacek J
    Mol Cell Biochem; 2007 Dec; 306(1-2):19-23. PubMed ID: 17653509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypolipidemic agents and their indication].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Residual lipid profile in recurrent ischemic cardiopathy].
    Millán J; Pedro-Botet J; Muñoz A; Corbella E; Mangas A; Zúñiga M; Hernández-Mijares A; Pintó X
    Med Clin (Barc); 2012 Mar; 138(6):238-41. PubMed ID: 21429535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.